Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
1.650
-0.075 (-4.35%)
At close: Nov 20, 2024, 4:00 PM
1.550
-0.100 (-6.06%)
After-hours: Nov 20, 2024, 7:20 PM EST
Evogene Revenue
Evogene had revenue of $914.00K in the quarter ending June 30, 2024, with 39.76% growth. This brings the company's revenue in the last twelve months to $9.45M, up 290.29% year-over-year. In the year 2023, Evogene had annual revenue of $5.64M with 236.72% growth.
Revenue (ttm)
$9.45M
Revenue Growth
+290.29%
P/S Ratio
n/a
Revenue / Employee
$66,542
Employees
142
Market Cap
9.21M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 5.64M | 3.97M | 236.72% |
| Dec 31, 2022 | 1.68M | 745.00K | 80.11% |
| Dec 31, 2021 | 930.00K | -110.00K | -10.58% |
| Dec 31, 2020 | 1.04M | 287.00K | 38.11% |
| Dec 31, 2019 | 753.00K | -994.00K | -56.90% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aytu BioPharma | 79.76M |
| Mobile-health Network Solutions | 13.97M |
| COSCIENS Biopharma | 4.83M |
| FOXO Technologies | 1.34M |
| Vaccinex | 388.00K |
| BioRestorative Therapies | 377.00K |
EVGN News
- 1 day ago - Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results - PRNewsWire
- 8 days ago - Lavie Bio Announces Commercial Expansion of Yalos® as Seed-Treatment for Soybean, Following Successful Field Trials - PRNewsWire
- 13 days ago - Evogene Schedules Third Quarter 2024 Financial Results Release - PRNewsWire
- 20 days ago - Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design - PRNewsWire
- 22 days ago - Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya - PRNewsWire
- 6 weeks ago - Watershed AC, Evogene and Ben-Gurion University Receive Approval for Second Year Grant to Continue the Collaboration Focused on Improving Crustacean Traits Utilizing Gene Editing Technology - PRNewsWire
- 7 weeks ago - Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-Biologicals - PRNewsWire
- 3 months ago - Evogene Announces Pricing of US$5.5 Million Registered Direct Offering and Concurrent Private Placement - PRNewsWire